Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma

Previous studies have shown that the expression level of stanniocalcin 2 (STC2) is associated with tumor progression. However, to date, the association between STC2 and clinicopathological factors in hepatocellular carcinoma (HCC) has not been investigated. The clinical significance of STC2 was inve...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, ZHEN-HAI, WU, YA-GUANG, QIN, CHENG-KUN, RONG, ZHONG-HOU, SU, ZHONG-XUE, XIAN, GUO-ZHE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186577/
https://www.ncbi.nlm.nih.gov/pubmed/25289096
http://dx.doi.org/10.3892/ol.2014.2520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186577/
https://www.ncbi.nlm.nih.gov/pubmed/25289096
http://dx.doi.org/10.3892/ol.2014.2520

Ejemplares similares